crohn's disease
Showing 1 - 25 of 644
Crohn's Disease Trial (MR Enterography (MRE))
Not yet recruiting
- Crohn's Disease
- MR Enterography (MRE)
- (no location specified)
Nov 13, 2023
Assess Participant-Reported Real-World Experience of
Recruiting
- Crohn's Disease
-
London, London, City Of, United KingdomGuys and St Thomas NHS Foundation Trust /ID# 258986
Nov 7, 2023
Ulcerative Colitis, Crohn's Disease Trial (Vedolizumab IV, Vedolizumab SC)
Not yet recruiting
- Ulcerative Colitis
- Crohn's Disease
- Vedolizumab IV
- Vedolizumab SC
- (no location specified)
Oct 17, 2023
Crohn's Disease Trial in Seoul (Infliximab-Dyyb)
Not yet recruiting
- Crohn's Disease
-
Seoul, Korea, Republic ofAsan Medical Center
Oct 5, 2023
Crohn's Disease Trial (Risankizumab SC, Placebo for risankizumab)
Not yet recruiting
- Crohn's Disease
- Risankizumab SC
- Placebo for risankizumab
- (no location specified)
Sep 26, 2023
Crohn's Disease Trial in Stockholm (AZD7798, [11C]AZ14132516)
Not yet recruiting
- Crohn's Disease
-
Stockholm, SwedenResearch Site
Sep 22, 2023
Crohn's Disease Trial in Chicago (Vedolizumab, Adalimumab, Ustekinumab)
Not yet recruiting
- Crohn's Disease
- Vedolizumab
- +2 more
-
Chicago, IllinoisUniversity of Chicago Medicine
Sep 13, 2023
Inflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis Trial in Valencia (TECCU Software)
Active, not recruiting
- Inflammatory Bowel Disease
- +3 more
- TECCU Software
-
Valencia, SpainHospital Universitario y Politécnico la Fe
Sep 1, 2023
Disease Activity and Adverse Events in Adolescent and Adult
Recruiting
- Crohn's Disease
-
Toyota-shi, Aichi, Japan
- +1 more
Aug 29, 2023
Assess Speed of Onset and Durability of Effectiveness of
Not yet recruiting
- Crohn's Disease
- (no location specified)
Jun 27, 2023
Ustekinumab in Treatment of Crohn's Disease
Completed
- Ustekinumab
- +3 more
-
Wenzhou, Zhejiang, ChinaSAHWenzhouMU
May 18, 2023
Disease Activity and Adverse Events In Adult Moderate to Severe
Recruiting
- Crohn's Disease
-
Calgary, Alberta, Canada
- +48 more
Apr 24, 2023
Crohn's Disease Trial (Vedolizumab IV, Placebo)
Not yet recruiting
- Crohn's Disease
- Vedolizumab IV
- Placebo
- (no location specified)
Apr 20, 2023
Perianal Fistula, Crohn's Disease Trial (ExoFlo, Local injection of normal saline)
Not yet recruiting
- Perianal Fistula
- Crohn's Disease
- ExoFlo
- Local injection of normal saline
- (no location specified)
Apr 19, 2023
Exclusive Enteral Nutrition in Adult Active Crohn's Disease
Completed
- Crohn's Disease
- exclusive enteral nutrition treatment group
- (no location specified)
Apr 14, 2023
Crohn's Disease, Ulcerative Colitis Trial (Samples)
Not yet recruiting
- Crohn's Disease
- Ulcerative Colitis
- Samples
- (no location specified)
Feb 8, 2023
Comorbidities and Complications in Inflammatory Bowel Disease
Enrolling by invitation
- Inflammatory Bowel Disease
- +2 more
-
Bethesda, Maryland
- +1 more
Feb 2, 2023
Crohn's Disease Trial in Worldwide (Guselkumab Dose 1, Guselkumab Dose 2, Guselkumab Dose 3)
Active, not recruiting
- Crohn's Disease
- Guselkumab Dose 1
- +7 more
-
Dothan, Alabama
- +574 more
Jan 31, 2023
A Multicenter, Prospective, Long-term, Observational Registry of
Active, not recruiting
- Crohn's Disease
- +3 more
- Anti TNF therapy including infliximab
- No Biologics
-
Mobile, Alabama
- +61 more
Jan 31, 2023
Crohn's Disease, Oral Ulcer Trial in Xi'an (Mesalazine Sustained-Release Tablets, Riboflavin Sodium Phosphate Injection)
Withdrawn
- Crohn's Disease
- Oral Ulcer
- Mesalazine Sustained-Release Tablets
- Riboflavin Sodium Phosphate Injection
-
Xi'an, Shaanxi, ChinaXijing Hospital
Jan 30, 2023
Crohn's Disease Trial in Hyderabad (Novel motorized spiral enteroscopy, Single balloon enteroscopy)
Recruiting
- Crohn's Disease
- Novel motorized spiral enteroscopy
- Single balloon enteroscopy
-
Hyderabad, Telangana, IndiaAsian Institute of Gastroenterology
Jan 29, 2023